Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b, Randomized, Double-Blind, Vehicle-Controlled Multi-Center Study of the Efficacy, Safety, and Tolerability of B244 Delivered as a Topical Spray in the Treatment of Moderate to Severe Acne Vulgaris

NCT07866105 is registered in ClinicalTrials.gov with AOBiome LLC as lead sponsor.

NCT NCT07866105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07866105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b, Randomized, Double-Blind, Vehicle-Controlled Multi-Center Study of the Efficacy, Safety, and Tolerability of B244 Delivered as a Topical Spray in the Treatment of Moderate to Severe Acne Vulgaris
Lead sponsor
AOBiome LLC
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
September 30, 2027
Enrollment
176 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris